Research on Dravet and refractory epilepsy doesn’t stop. On October 3 and 4, we were able to hear live the latest news and advances in the fight against these diseases. We would like to congratulate Basque Centre for Neuroscience Research Achucarro, the University of the Basque Country and ApoyoDravet for the excellent organization of the event.
We had the pleasure of attending the II International Congress on Dravet Syndrome and Refractory Epilepsy in the city of Bilbao. The three organizing entities, the Basque Centre for Neuroscience Research Achucarro, the University of the Basque Country and ApoyoDravet, who once again brought together doctors, researchers, family members, educators and other participants to share knowledge and advance in the modification of these diseases.
As novelties, this year a whole specific afternoon has been incorporated for the knowledge of the medicines and technological devices that are being developed.
Without a doubt, the International Congress on Dravet Syndrome and Refractory Epilepsy has become a benchmark congress in its field.
We were able to share experiences with more than 25 experts from different fields who gave us the latest news during meals and coffees.
MJN made a presentation on how our project approaches the problem of the unpredictability of epilepsy crises and how using the most modern technologies in terms of data processing, use of algorithms and automatic learning Machine Learning systems, it is possible to “teach” different algorithms to assess the risk of suffering an epilepsy crisis at a given time. We were also able to explain how this whole process is carried out in a totally individualized way since at MJN we think that each epileptic seizure is unique.
From here, we would like to congratulate Dr. Luismi Aras for the excellent organization and the treatment we received. We would like to thank Adrián Trejo, responsible for pediatrics at Clínica Corachan, for accompanying us during the 2 days. And to make a special remark about Dr. Antonio Gil-Nagel for his extraordinary presentation on the future of epilepsy treatment and the relaxed conversation we were able to have with him during the congress.
Without a doubt, the International Congress on Dravet Syndrome and Refractory Epilepsy has become a benchmark congress in its field.
